Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Fresenius Medical Care Corp (FMS)

Fresenius Medical Care Corp (FMS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Fresenius Medical (FMS) Q4 Earnings Beat Estimates, Up Y/Y

Fresenius Medical's (FMS) fourth-quarter earnings benefit from strong segmental performance and solid 2020 EPS outlook.

SYK : 224.30 (-0.08%)
ARAY : 3.32 (-1.48%)
FMS : 41.01 (-2.40%)
IDXX : 278.11 (-1.19%)
Should Value Investors Pick Fresenius Medical (FMS) Stock?

Let's see if Fresenius Medical (FMS) stock is a good choice for value-oriented investors right now from multiple angles.

FMS : 41.01 (-2.40%)
Fresenius (FMS) Upgraded to Buy: Here's What You Should Know

Fresenius (FMS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

FMS : 41.01 (-2.40%)
Is Fresenius (FMS) a Great Value Stock Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

FMS : 41.01 (-2.40%)
Should Value Investors Buy Fresenius (FMS) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

FMS : 41.01 (-2.40%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fresenius Medical Care AG & Co. KGaA - FMS

Pomerantz LLP is investigating claims on behalf of investors of Fresenius Medical Care AG & Co. KGaA ("Fresenius" or the "Company") (NYSE: FMS). Such investors are advised to contact Robert S. Willoughby...

FMS : 41.01 (-2.40%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fresenius Medical Care AG & Co. KGaA - FMS

Pomerantz LLP is investigating claims on behalf of investors of Fresenius Medical Care AG & Co. KGaA ("Fresenius" or the "Company") (NYSE: FMS). Such investors are advised to contact Robert S. Willoughby...

FMS : 41.01 (-2.40%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Fresenius Medical Care AG & Co. KGaA - FMS

Pomerantz LLP is investigating claims on behalf of investors of Fresenius Medical Care AG & Co. KGaA ("Fresenius" or the "Company") (NYSE: FMS). Such investors are advised to contact Robert S. Willoughby...

FMS : 41.01 (-2.40%)
Should Value Investors Buy Fresenius (FMS) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

FMS : 41.01 (-2.40%)
Fresenius Medical Care Celebrates 10th Anniversary and Expansion of Their Dialysis Center With Enhanced Home Therapy Support in Perth, Western Australia

Fresenius Medical Care, the world's leading provider of dialysis products and services, announced the further enhancement of support for home dialysis patients in Western Australia. Celebrating the 10th...

FMS : 41.01 (-2.40%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fresenius Medical Care AG & Co. KGaA - FMS

Pomerantz LLP is investigating claims on behalf of investors of Fresenius Medical Care AG & Co. KGaA ("Fresenius" or the "Company") (NYSE: FMS). Such investors are advised to contact Robert S. Willoughby...

FMS : 41.01 (-2.40%)
More People in Phnom Penh Living With Kidney Disease Will Have Access to Dialysis From Today

Fresenius Medical Care, the world's leading provider of dialysis products and services, has collaborated with Hebron Medical Center (HMC) to bring high-quality, affordable dialysis treatment to Cambodian...

FMS : 41.01 (-2.40%)
Here's Why You Should Retain Ecolab (ECL) Stock For Now

Ecolab (ECL) continues to gain from robust product portfolio and strong international presence. However, forex remains a woe.

ECL : 207.50 (+0.58%)
FMS : 41.01 (-2.40%)
MCK : 170.96 (+0.11%)
NNCHY : 41.5900 (+0.90%)
Here's Why You Should Hold on to PerkinElmer (PKI) Stock Now

PerkinElmer (PKI) is gaining steadily from the core Diagnostics segment, prudent acquisitions and margin expansion. However, forex volatility remains a concern.

PKI : 92.85 (-0.48%)
FMS : 41.01 (-2.40%)
MCK : 170.96 (+0.11%)
NNCHY : 41.5900 (+0.90%)
Here's Why You Should Retain Cooper Companies (COO) Stock Now

Cooper Companies (COO) is gaining traction from expansion in international markets, robust product portfolio across segments and prudent acquisitions. However, forex continues to remain a concern.

FMS : 41.01 (-2.40%)
COO : 355.67 (+0.24%)
MCK : 170.96 (+0.11%)
NNCHY : 41.5900 (+0.90%)
Is Fresenius (FMS) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

FMS : 41.01 (-2.40%)
Here's Why You Should Retain DaVita (DVA) Stock for Now

DaVita (DVA) is gaining steadily from expansion in international markets, strong demand in dialysis services and prudent acquisitions. However, integration risks remain a concern.

FMS : 41.01 (-2.40%)
DVA : 84.09 (-0.66%)
MCK : 170.96 (+0.11%)
NNCHY : 41.5900 (+0.90%)
Integer Holdings (ITGR) Boosts Product Line with New Buyout

Integer Holdings' (ITGR) buyout is likely to add differentiated capability for complex braided and formed biomedical structures to the company's existing product portfolio.

ITGR : 97.85 (-1.09%)
FMS : 41.01 (-2.40%)
MCK : 170.96 (+0.11%)
NNCHY : 41.5900 (+0.90%)
Fresenius Medical Launches 4008A Dialysis Machine in China

Fresenius Medical (FMS) aims to treat ESRD patients in remote locations of China.

FMS : 41.01 (-2.40%)
MASI : 178.37 (-1.89%)
BAX : 92.67 (-0.42%)
CNMD : 103.55 (-0.31%)
Fresenius Medical Care Launches 4008A(TM) Dialysis Machine in China

Fresenius Medical Care, the world's leading provider of dialysis products and services, today announced the launch of its 4008A(TM) dialysis machine in China. The product is exclusively designed to incorporate...

FMS : 41.01 (-2.40%)

Van Meerten Stock Picks

My 5 Favorite Mid Caps
Summary 100% technical buy signals with current momentum.
CRUS -1.55 , SEDG -0.13 , THC +1.65 , TER -1.89 , LITE -3.16
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar